Professional Polish Investment Research - Expert Analysis for Foreign Investors

Creotech S.A.

CRI.WA Technology
space-technology satellites earth-observation defence quantum-technologies esa dual-use
146.8M LTM Revenue (PLN)
-12.4% Revenue Growth (YoY)

Company Overview

Creotech S.A. (Creotech Instruments) is a Polish deep-tech company operating primarily in space systems and advanced electronics. The company designs and integrates small satellite platforms (HyperSat), delivers complete Earth-observation systems, manufactures space-grade electronics, and develops solutions in quantum communication and quantum computing control systems. Creotech serves mainly institutional clients, including the European Space Agency (ESA), national space agencies, and defence institutions. Its growth is driven by large multi-year government and ESA contracts such as Mikroglob and CAMILA.

Business Segments

  • Space systems and satellite platforms
  • Earth observation constellations and ground segment
  • Space-grade electronics manufacturing
  • Quantum communication and quantum computing electronics
  • Geospatial data processing and UAV solutions

Key Drivers

  • Execution of large multi-year contracts (Mikroglob, CAMILA)
  • Growing European and Polish defence and space spending
  • ESA programs and dual-use space initiatives
  • Expansion of small satellite and Earth-observation markets
  • Spin-off strategy unlocking value in quantum and UAV segments

Key Risks

  • High dependence on a small number of large contracts
  • Project execution risk and milestone-based revenue volatility
  • Capital intensity and potential future dilution
  • Technology and delivery risk in complex space missions
  • Timing mismatch between costs and revenue recognition

What to Watch

  • Progress and invoicing milestones on Mikroglob and CAMILA
  • New ESA and defence contract wins post-2025
  • Cash flow evolution during project ramp-up
  • Execution of quantum and UAV spin-offs
  • Backlog replenishment beyond 2027

Foundational Analysis

Foundational Analysis v1.0 Last updated: 2025-12-31

Business Model

Creotech operates a project-based deep-technology model focused on long-term institutional contracts. Revenues are recognized based on milestone completion under multi-year space and defence programs. The company combines systems integration, hardware manufacturing, and R&D-driven engineering.

Competitive Positioning

Creotech is the leading Polish supplier of space technologies and one of the few regional players capable of acting as a prime contractor for full satellite systems. Its advantages include ESA credibility, proprietary satellite platforms, in-house electronics manufacturing, and strong positioning in dual-use space programs.

Economics & Capital Allocation

The company shows strong operating leverage once major projects reach scale, but reported profitability is volatile due to milestone-based revenue recognition and upfront cost absorption. EBITDA turned positive in 2025, while net profit remains temporarily negative at the TTM level.

Capital allocation is growth-oriented, focused on financing large contracts and strategic expansion. The company raised equity in 2025 to fund Mikroglob and CAMILA, avoids financial debt, and does not pay dividends, reinvesting all cash flows into development.

Long-term Risks

Sustained reliance on government programs, execution complexity of flagship projects, dilution risk from future capital raises, and uncertainty around commercialization timelines for quantum technologies.

What Would Break the Thesis

  • Material delays or cost overruns on Mikroglob or CAMILA
  • Loss or cancellation of key institutional contracts
  • Inability to secure new large projects after 2027
  • Structural cash flow stress forcing unfavorable dilution

Full Company Analysis

Creotech Instruments Analysis

Analysis version: December 2025

Purchase the full, in-depth research report for Creotech S.A., including the complete foundational analysis, valuation scenarios, and investment thesis.

€19

Secure checkout via Stripe

Contracts Intelligence

Currency Note: All amounts in PLN. Foreign currency contracts converted at announcement date rates.

Contract 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3 2027 Q4 2028 Q1 2028 Q2 2028 Q3 2028 Q4 2029 Q1 2029 Q2 2029 Q3 2029 Q4 2030 Q1 Total
Total Revenue per Quarter 2,079,944.37 64,498,289.87 10,867,376.58 12,698,660.73 9,255,954.60 6,748,942.17 6,826,700.90 146,445.02 146,445.02 166,940.60 146,445.02 146,445.02 146,445.02 166,940.64 146,445.02 146,445.02 29,423.57 32,365.93 29,423.57 114,426,078.67
Placement Agreement for Series M Shares Public Offering
View Source 2026-06-08 - 2027-06-08
- - - - - - - - - - - - - - - - - - - -
Option Agreement to Subscribe for Thorium Space S.A. Shares
View Source 2026-05-29 - 2027-05-29
- - - - - - - - - - - - - - - - - - - -
Mikroglob Satellite Earth Observation System Project
View Source 2026-05-28 - 2027-03-31
- - - - - - - - - - - - - - - - - - - -
Cooperation and Confidentiality Agreement for Joint Development and Commercialisation of Quantum-Enabled Biometric Gateway
View Source 2026-05-15 - 2027-05-15
- - - - - - - - - - - - - - - - - - - -
Research Project: Innovative Satellite System for Large-Mass Payloads
View Source 2026-03-12 - 2027-03-12
- - 5,094,442.35 5,094,442.35 5,094,442.35 5,094,442.35 5,858,608.69 - - - - - - - - - - - - 26,236,378.09
LEO-PNT - HyperSat SAFIR-PNT Project (Phase 1) with ESA
View Source 2026-02-12 - 2026-10-12
- - 507,602.42 507,602.42 507,602.42 583,742.74 - - - - - - - - - - - - - 2,106,550.00
MULTI-MISSION PLATFORM TRANSPORT DEMONSTRATION - PRELIMINARY DESIGN (PHASE B1)
View Source 2026-02-06 - 2027-02-05
- - 620,220.57 620,220.57 620,220.57 682,242.66 620,220.57 - - - - - - - - - - - - 3,163,124.94
Multi-purpose Quantum Key Distribution (QKD) receiver for optical ground stations - design, build and proof-of-concept demonstration
View Source 2026-01-08 - 2027-01-08
- - 201,430.75 201,430.75 201,430.75 221,573.82 201,426.62 - - - - - - - - - - - - 1,027,292.69
PIONIER-Q-SAT project - construction of transboundary Quantum Key Distribution (QKD) link with a mobile ground station for the European Commission
View Source 2026-01-01 - 2029-06-30
- - 117,021.45 117,021.45 117,021.45 134,574.67 117,021.45 117,021.45 117,021.45 134,574.67 117,021.45 117,021.45 117,021.45 134,574.71 117,021.45 117,021.45 - - - 1,690,960.00
Phase A for High-Resolution Mineralogy Mapper Mission - EXPRO PLUS
View Source 2025-12-19 - 2026-09-19
- 698,821.94 635,292.69 635,292.69 635,292.69 - - - - - - - - - - - - - - 2,604,700.01
CAMILA - Country Awareness Mission in Land Analysis (Requirements Key Point review)
View Source 2025-11-26 - None
- 4,905,236.67 - - - - - - - - - - - - - - - - - 4,905,236.67
Radio Communication System - CERBER
View Source 2025-09-26 - 2026-09-25
2,050,520.80 2,255,572.88 2,050,520.80 2,050,520.80 2,050,520.80 - - - - - - - - - - - - - - 10,457,656.08
Subcontract for BLAM (Background Light and Atmosphere Metrology) subsystem design and manufacture
View Source 2025-04-30 - 2030-04-30
29,423.57 32,365.93 29,423.57 29,423.57 29,423.57 32,365.93 29,423.57 29,423.57 29,423.57 32,365.93 29,423.57 29,423.57 29,423.57 32,365.93 29,423.57 29,423.57 29,423.57 32,365.93 29,423.57 573,759.63
Mikroglob Satellite Earth Observation System manufacturing and delivery agreement
View Source 2024-12-20 - 2027-03-31
- 51,706,851.06 - - - - - - - - - - - - - - - - - 51,706,851.06
COUNTRY AWARENESS MISSION IN LAND ANALYSIS (CAMILA) - Requirements Key Point Review (ESA)
View Source None - None
- 4,899,441.39 - - - - - - - - - - - - - - - - - 4,899,441.39
CAMILA - Country Awareness Mission in Land Analysis (ESA) - Milestone 3/3a Completion
View Source None - None
- - 1,611,421.98 - - - - - - - - - - - - - - - - 1,611,421.98
COUNTRY AWARENESS MISSION IN LAND ANALYSIS - CAMILA (Supplementary remuneration for Milestone 2)
View Source None - None
- - - 3,442,706.13 - - - - - - - - - - - - - - - 3,442,706.13

AI-Generated Revenue Allocation: Revenue allocations follow IFRS 15 principles with AI-derived timing assumptions. Verify with official financial statements.

Financial Performance

PLN Showing 10 quarters | Metric: Revenue (Quarterly)

Quarterly Data

Metric 2023Q4 2024Q1 2024Q2 2024Q3 2024Q4 2025Q1 2025Q2 2025Q3 2025Q4 2026Q1
Income Statement Revenue (Quarterly) 30.7M 8.8M 8.3M 5.9M 2.7M 25.5M 48.9M 20.6M 54.9M 22.4M
Income Statement Gross Profit (Quarterly) 0 -3.8M -5.3M 9.2M -32.8M 1.4M 2.6M -8.7M 29.6M -6.1M
Income Statement EBITDA (Quarterly) -8.6M -2.0M -3.1M -6.1M -5.7M 4.5M 6.4M -5.1M 32.3M -4.9M
Income Statement EBIT (Quarterly) -16.9M -4.0M -5.2M -8.0M -7.7M 1.4M 2.6M -8.7M 29.6M -8.7M
Income Statement Net Income (Quarterly) -14.3M -3.3M -4.2M -7.0M -5.9M 1.4M 2.1M -6.6M 23.0M -6.9M
Costs Selling & Distribution Costs 0 0 0 0 0 0 0 0 0 0
Costs Administrative Expenses 0 0 0 0 0 0 0 0 0 0
Cash Flow Operating Cash Flow 15.5M -4.2M 2.3M -3.1M -13.5M 13.0M 41.8M -29.0M 23.9M -36.4M
Cash Flow Capital Expenditure 22.6M 5.6M 5.3M 4.7M 4.3M 12.7M 3.8M 6.1M 4.7M -6.8M
Cash Flow Free Cash Flow -7.1M -9.9M -3.0M -7.8M -17.8M 348.0K 38.0M -35.1M 19.1M -29.6M
Cash Flow Depreciation & Amortization 8.2M 2.0M 2.0M 1.9M 2.0M 3.1M 3.8M 3.7M 3.7M 3.7M
LTM Metrics Revenue (LTM) 30.7M 39.5M 47.8M 53.7M 25.7M 42.5M 83.1M 97.8M 150.0M 146.8M
LTM Metrics EBITDA (LTM) -8.6M -10.6M -13.7M -19.8M -16.9M -10.4M -844.0K 173.0K 38.1M 28.6M
LTM Metrics Net Income (LTM) -14.3M -17.7M -21.9M -28.9M -20.5M -15.7M -9.4M -8.9M 19.9M 11.6M
Profitability Gross Margin 0.0% -43.9% -63.7% 156.2% -1195.4% 5.4% 5.3% -42.3% 53.9% -27.1%
Profitability EBITDA Margin -28.1% -22.3% -37.8% -103.7% -207.2% 17.7% 13.1% -24.5% 58.7% -22.1%
Profitability EBIT Margin -54.9% -45.1% -62.2% -136.8% -280.4% 5.4% 5.3% -42.4% 53.9% -38.7%
Profitability Net Margin -46.7% -38.0% -50.6% -119.5% -215.5% 5.5% 4.4% -31.9% 41.8% -30.7%
Profitability ROIC -32.6% -50.6% -67.8% -88.5% -45.5% -29.6% -17.4% -28.8% 51.0% 16.4%
Profitability Cash Conversion -108.0% 127.0% -55.0% 45.0% 229.0% 927.0% 1956.0% 441.0% 104.0% 530.0%
Balance Sheet Current Assets 95.4M 85.7M 78.7M 69.4M 54.8M 135.4M 183.5M 196.8M 191.7M 151.9M
Balance Sheet Current Liabilities 24.0M 21.8M 19.1M 21.2M 29.6M 49.6M 99.7M 120.4M 114.3M 97.5M
Balance Sheet Inventories 9.6M 10.3M 10.7M 10.4M 8.9M 9.3M 9.5M 18.6M 15.9M 18.9M
Balance Sheet Trade Receivables 5.1M 12.5M 7.8M 7.1M 7.3M 15.5M 18.8M 21.1M 23.4M 36.0M
Balance Sheet Trade Payables 8.4M 17.7M 15.8M 14.6M 4.8M 32.4M 64.5M 94.0M 6.7M 19.5M
Balance Sheet Total Equity 91.4M 88.0M 83.8M 76.8M 71.0M 145.2M 147.3M 140.7M 159.0M 140.7M
Balance Sheet Total Debt 24.0M 2.0K 0 0 22.5M 0 1.0K 1.0K 20.9M 4.0K
Balance Sheet Cash & Equivalents 73.2M 62.7M 59.8M 51.2M 32.4M 106.0M 142.9M 108.1M 115.0M 83.9M
Balance Sheet Invested Capital 42.2M 25.4M 24.1M 25.6M 61.1M 39.1M 4.4M 32.7M 64.9M 56.9M
Balance Sheet Net Working Capital 6.4M 5.0M 2.8M 2.9M 11.5M -7.6M -36.2M -54.3M 32.6M 35.4M
Ratios Current Ratio 3.97 3.94 4.12 3.27 1.85 2.73 1.84 1.63 1.68 1.56
Ratios Net Working Capital to Revenue 0.21 0.58 0.33 0.49 4.19 -0.30 -0.74 -2.63 0.59 1.58

Revenue (Quarterly) - Visual Analysis

Revenue (Quarterly) (PLN)
Growth Rates (QoQ% and YoY%)
Quarter-over-Quarter Year-over-Year

Data Source: Financial data sourced from company filings and periodic reports. Values in PLN. Margins and ratios stored as decimals converted to percentages for display.

Recent News & Developments

Sentiment Analysis (Last 6 Months)
Positive 87%
Neutral 7%
Negative 5%

Based on 55 articles

2026-06-08
ESPI positive

Creotech Instruments S.A. Launches Public Offering of Series M Shares to Fund Strategic Growth

Creotech Instruments S.A., a leading Polish high-technology company specializing in space technologies, quantum systems, and advanced electronics manufacturing, has announced the commencement of a public offering of up to 650,000 Series M ordinary bearer shares. The offering, conducted through an accelerated bookbuilding process, is targeted at qualified investors and those subscribing for shares worth at least EUR 100,000. The proceeds from the issuance will be allocated to support the company’s 2026-2029 Development Strategy, which includes:

  • 40%-60%: Investment in production and R&D infrastructure.
  • 20%-30%: Financing research and development, particularly for new satellite platforms and quantum technologies.
  • 20%-30%: Funding potential acquisitions, strategic partnerships, international expansion, and operational costs.

The offering is being managed by a consortium of financial institutions, including UniCredit Bank GmbH, J.P. Morgan SE, Trigon Dom Maklerski S.A., and PKO BP. The final number of shares and their issue price will be determined based on the results of the bookbuilding process, which is set to conclude by June 12, 2026. The company has also committed to a 180-day lock-up period, during which it will not issue new shares without prior consent from the offering managers.

The funds raised will enable Creotech to expand its production capabilities, accelerate R&D efforts, and pursue strategic growth opportunities, aligning with its mission to strengthen its position in the space and quantum technology sectors.

Relevance to Creotech S.A.: This public offering is directly tied to Creotech's strategic goals of advancing its satellite and quantum technology platforms, expanding its production infrastructure, and supporting its international growth ambitions.

View source
2026-06-03
ESPI positive

Creotech Instruments S.A. Announces Key Resolutions from Annual General Meeting

On June 3, 2026, Creotech Instruments S.A., a leading Polish high-technology company specializing in space technologies, quantum systems, and advanced electronics manufacturing, held its Annual General Meeting (AGM) in Piaseczno. The meeting resulted in the adoption of several significant resolutions aimed at supporting the company’s strategic growth and operational goals.

Key resolutions included the approval of the company’s financial statements for 2025, which reported a net profit of PLN 13.57 million and an increase in equity by PLN 88.06 million. The AGM also approved the allocation of the entire 2025 net profit to the company’s reserve capital to support future investments and expansion. Additionally, the board members and supervisory board members were granted discharge of their duties for the fiscal year 2025.

One of the most notable resolutions was the decision to increase the company’s share capital by issuing up to 650,000 new Series M shares through a private subscription, with the exclusion of pre-emptive rights for existing shareholders. This move aims to raise funds for the implementation of Creotech’s strategic plan for 2026–2029. The AGM also approved the establishment of a new incentive program for the company’s CEO, Grzegorz Konrad Brona, which includes the issuance of up to 103,600 subscription warrants tied to performance-based milestones.

These resolutions reflect Creotech’s commitment to strengthening its position in the space and quantum technology sectors, as well as its focus on long-term growth and shareholder value.

Relevance to Creotech S.A. Business Profile: The AGM resolutions align with Creotech’s strategic focus on expanding its capabilities in satellite and quantum technologies, leveraging increased European space and defense budgets, and accessing R&D grants to support its growth initiatives.

View source
2026-06-02
ESPI neutral

Creotech Instruments Faces Financial Challenges Amid Strategic Restructuring

Creotech Instruments S.A., a leading Polish high-tech company specializing in space technologies, quantum systems, and advanced electronics manufacturing, reported mixed financial results for Q1 2026. The company recorded a net loss of PLN 6.87 million, a stark contrast to the net profit of PLN 1.4 million in the same period last year. Revenues from continued operations fell to PLN 16.8 million, down from PLN 19.9 million year-on-year, primarily due to project scheduling adjustments. Operating costs surged by PLN 9.7 million, driven by increased employee compensation, social insurance, and subcontractor expenses for key projects such as Mikroglob and CAMILA.

In a significant development, Creotech completed the spin-off of its quantum systems segment into a new entity, Creotech Quantum S.A., in April 2026. The spin-off resulted in the issuance of Creotech Quantum shares to existing shareholders, with the value of the transferred assets significantly exceeding their book value. This transaction is expected to impact the company's financial results in Q2 2026.

Despite the financial setbacks, Creotech achieved several operational milestones, including the successful launch phases of satellites in the PIAST constellation and the acceptance of key milestones in the CAMILA project by the European Space Agency (ESA). The company also initiated a public offering of up to 650,000 new shares to raise approximately EUR 100 million for its 2026-2029 strategic development plan.

Creotech's future performance will depend on securing new ESA contracts, the success of its public offering, and the timely execution of ongoing projects. The company remains optimistic about its growth potential, supported by increased Polish contributions to ESA and the development of the national space industry ecosystem.

Relevance to Creotech S.A.: The article highlights Creotech's financial performance, strategic restructuring, and ongoing projects, which are directly tied to its core business areas of space technologies, quantum systems, and advanced electronics manufacturing.

View source
2026-06-02
ESPI neutral

Creotech Quantum S.A. Reports Financial Losses in Q1 2026 Amid Strategic Developments

Creotech Quantum S.A., a subsidiary of Creotech Instruments S.A., reported a net loss of PLN 44,000 for the first quarter of 2026, reflecting the company's early-stage operational challenges following its spin-off from Creotech Instruments S.A. The company did not generate revenue during the quarter, with operational costs primarily driven by employee wages and social insurance contributions, accounting for 60% of total expenses.

Key developments during the quarter included the signing of a strategic contract with the European Space Agency (ESA) for the "Multi-purpose Quantum Key Distribution receiver for optical ground stations" project. Creotech Quantum will act as a subcontractor to OHB System AG, contributing control electronics and single-photon detectors valued at approximately EUR 300,000. Additionally, the company relocated its operations to a new facility in Warsaw and continued preparations for its independent operations post-spin-off.

Creotech Quantum also successfully completed an IPO, raising PLN 81.2 million through the issuance of 350,000 Series D shares at PLN 232 per share. The funds will be allocated to research and development, infrastructure expansion, and scaling production capabilities.

Despite the financial losses, the company remains optimistic about its growth prospects, citing increased European defense and space budgets, rising demand for quantum communication technologies, and access to EU and Polish R&D grants as positive drivers for future development.

Relevance to Creotech Instruments S.A.: This article highlights the strategic initiatives and financial challenges of Creotech Quantum S.A., a spin-off from Creotech Instruments S.A., showcasing the parent company's expansion into quantum technologies and its alignment with European space and defense priorities.

View source
2026-06-02
Biznes PAP positive

Creotech Instruments Reports Q1 2026 Financial Results and Strategic Developments

Polish high-tech company Creotech Instruments S.A. has reported total revenues of approximately PLN 27 million for Q1 2026, up from PLN 25.5 million in the same period last year. The company’s backlog for 2026 stood at PLN 254.7 million as of the end of 2025, reflecting strong future commitments. The space projects segment contributed the largest share of revenue, accounting for 71.5% of total sales.

Despite a net loss of PLN 5.4 million in Q1 2026, attributed to increased operational costs and a non-cash motivational program, Creotech maintained a robust financial position with cash reserves of PLN 84 million as of March 2026. The company highlighted that revenue recognition for its major space projects, including Mikroglob and CAMILA, is tied to milestone achievements, which are unevenly distributed across the project timelines.

Additionally, Creotech completed the spin-off of its quantum technology division into a new entity, Creotech Quantum, on April 1, 2026. The fair value of the spun-off segment was estimated at PLN 698.4 million. Creotech Quantum generated PLN 9 million in revenue and a net profit of PLN 1.5 million in Q1 2026.

Looking ahead, Creotech has adopted a new development strategy for 2026–2029, aiming to expand its operations and strengthen its position in the European space market. To support this growth, the company announced a plan to issue up to 650,000 new shares in May 2026 to raise additional capital.

Creotech’s CEO, Grzegorz Brona, emphasized the company’s focus on achieving key milestones in its largest space projects, which are expected to drive revenue growth in the coming quarters. The company also continues to work on projects for the European Space Agency (ESA), the European Commission, and national institutions, ensuring high operational activity.

Relevance to Creotech S.A. Business Profile

This article highlights Creotech’s core activities in space technologies and quantum systems, as well as its strategic focus on expanding its presence in the European space industry. The financial results and project updates underscore the company’s role in delivering advanced satellite and quantum solutions, aligning with its business profile and growth objectives.

View source
2026-05-29
ESPI positive

Creotech Instruments S.A. Gains Approval for Series D Shares on Warsaw Stock Exchange

Creotech Instruments S.A., a leading Polish high-technology company specializing in space technologies and quantum systems, has announced that the Warsaw Stock Exchange (WSE) has approved the admission and introduction of 350,000 Series D ordinary bearer shares to trading on its main market. The decision, formalized through Resolution No. 759/2026, was made on May 29, 2026. The shares, identified by ISIN code PLCTHQM00034, are set to commence trading on June 3, 2026, contingent upon their registration in the securities depository managed by Krajowy Depozyt Papierów Wartościowych (KDPW) by the same date.

This development marks a significant milestone for Creotech, as the new share issuance is expected to support the company’s ongoing expansion and R&D initiatives in satellite production, quantum communication, and advanced electronics manufacturing.

Relevance: The approval of Series D shares aligns with Creotech’s growth strategy, providing critical funding for its ambitious projects, including the development of its proprietary HyperSat platform and quantum communication technologies.

View source
2026-05-29
ESPI positive

Creotech Instruments S.A. Raises PLN 81.2 Million Through Private Share Offering

Creotech Instruments S.A., a leading Polish high-technology company specializing in space technologies, quantum systems, and advanced electronics manufacturing, has successfully completed a private subscription offering of 350,000 Series D ordinary shares. The offering, conducted between May 15 and May 22, 2026, raised a total of PLN 81.2 million, with each share priced at PLN 232. The company secured commitments from 61 investors, with all shares fully subscribed. The raised capital will support Creotech’s ongoing expansion and development projects, including its proprietary HyperSat satellite platform and quantum communication technologies.

The company’s management confirmed the increase in share capital on May 25, 2026, and announced plans to list the new shares on the Warsaw Stock Exchange. The final costs associated with the share issuance will be disclosed in a separate report once all financial documentation is finalized.

Relevance to Creotech S.A.: The successful capital raise strengthens Creotech’s financial position, enabling the company to fund its ambitious projects in satellite production, quantum communication, and advanced electronics, aligning with its strategic growth objectives in the space and quantum technology sectors.

View source
2026-05-29
ESPI positive

Creotech Instruments S.A. Secures Strategic Investment Option in Thorium Space S.A.

On May 29, 2026, Creotech Instruments S.A., a leading Polish high-technology company, announced the signing of an option agreement with Thorium Space S.A., a Wrocław-based space technology firm. The agreement grants Creotech the right to acquire 1,100,560 Series I shares in Thorium Space, representing approximately 19.99% of Thorium's share capital and voting rights at its general meeting. The nominal value of the shares is PLN 0.10 each, with a total nominal value of PLN 110,056. The subscription price per share will be determined based on Thorium's public offering price, with a 20% discount, and will range between PLN 25 and PLN 30 per share.

The option is contingent upon Thorium's Supervisory Board and General Meeting approving resolutions to conditionally increase its share capital and issue subscription warrants. Creotech will be eligible to exercise the option between one and four years after Thorium's shares are listed on the Warsaw Stock Exchange or the NewConnect market. Additionally, the agreement grants Creotech the right to appoint a member to Thorium's supervisory board upon reaching specific shareholding thresholds.

This strategic move aligns with Creotech's focus on expanding its footprint in the space technology sector and fostering collaborations within Poland's growing space industry ecosystem.

Relevance to Creotech S.A.: This agreement strengthens Creotech's position in the space technology sector and aligns with its strategy to support the development of Poland's space industry ecosystem, a key driver for its business growth.

View source
2026-05-28
ESPI positive

Creotech Instruments Secures License for "Mikroglob" Earth Observation Satellite System

Creotech Instruments S.A., a leading Polish high-technology company, has announced the receipt of a license from the President of the Polish Space Agency (POLSA) to conduct space activities under the Space Activities Act of February 13, 2026. The license pertains to the implementation of the "Mikroglob" Earth Observation Satellite System (SSOZ) project. The project is scheduled for completion by March 31, 2027. While specific details of the project timeline and conditions remain confidential due to national security considerations, this development marks a significant milestone for Creotech's involvement in advancing Poland's space capabilities.

Relevance to Creotech S.A.: This achievement aligns with Creotech's strategic focus on satellite development and its role in bolstering Poland's space industry ecosystem, as well as its commitment to delivering complex projects like "Mikroglob" that contribute to national security and technological advancement.

View source
2026-05-27
ESPI positive

Creotech Instruments S.A. Announces Capital Increase and Statute Amendments

On May 27, 2026, Creotech Instruments S.A., a leading Polish high-technology company specializing in space technologies, quantum systems, and advanced electronics manufacturing, announced the registration of amendments to its corporate statute by the District Court for the Capital City of Warsaw. The changes, approved during the Extraordinary General Meeting on January 21, 2026, include a conditional increase in the company's share capital by up to PLN 21,407.70 through the issuance of up to 214,077 Series C ordinary bearer shares. These shares are tied to Series A subscription warrants, granting holders the right to acquire Series C shares by December 31, 2030. Additionally, the company updated its registered address to ul. Migdałowa 4, 02-796 Warsaw.

The amendments also revised the company's statute to allow for the undertaking of financial obligations exceeding PLN 1,000,000. This move is part of Creotech's broader strategy to secure funding for its ambitious growth plans, including the development of its proprietary HyperSat satellite platform and quantum communication technologies.

Relevance to Creotech S.A.: The capital increase and statute amendments are critical for Creotech's ability to fund its expansion and execute large-scale projects, aligning with its strategic focus on space and quantum technologies.

View source

2026 EPS Estimates

Last updated: 2025-12-31
Bear Case
2026 EPS: PLN None
Assumptions:
  • Execution delays, margin pressure, and higher-than-expected dilution
Base Case
2026 EPS: PLN None
Assumptions:
  • Successful execution of Mikroglob and CAMILA with gradual margin normalization
Bull Case
2026 EPS: PLN None
Assumptions:
  • Additional ESA and defence contracts, strong execution, and value unlocked through spin-offs

Note: EPS estimates are for informational purposes only and represent our analytical framework, not investment recommendations. These financial results estimates are based on stated assumptions and may change as new information becomes available.

Key Metrics

Company-specific performance indicators tailored to Creotech S.A.'s business model.

No key metrics available yet

Custom performance indicators for Creotech S.A. will appear here once available.

Examples of metrics we track:

Recurring Revenue
Order Backlog
MRR/ARR
Customer Count
ARPU

Data Source: Key metrics are extracted from company disclosures, periodic reports, and management commentary.

Periodic Report Publication Calendar

FY 2026 Last updated: 2026-04-28
Quarter Publication date
Q1 2026-06-01
H1 2026-09-28
Q3 2026-11-26

View source ESPI report

FY 2025 Last updated: 2026-04-28
Quarter Publication date
FY 2026-04-30

View source ESPI report

Schedule reflects the most recent ESPI announcement for each fiscal year. Past publication dates are shown in grey.